Table 1 Clinicopathological characteristics of the patients
Pathology | All patients n (%) | Menopausal status | |
|---|---|---|---|
Pre- n (%) | Post- n (%) | ||
Benign ovarian diseases | 128 | 87 | 41 |
 Histologic type | |||
 Serous | 46 (35.9) | 25 (28.7) | 21 (51.2) |
 Mucinous | 13 (10.2) | 7 (8.1) | 6 (14.6) |
 Endometriosis | 33 (25.8) | 31 (35.6) | 2 (4.9) |
 Mixed | 12 (9.4) | 8 (9.2) | 4 (9.8) |
 Other | 24 (18.7) | 16 (18.4) | 8 (19.5) |
Epithelial ovarian cancer | 96 | 33 | 63 |
 Histologic type | |||
 Serous | 59 (61.5) | 17 (51.4) | 42 (66.7) |
 Endometrioid | 13 (13.5) | 5 (15.2) | 8 (12.7) |
 Mucinous | 10 (10.4) | 6 (18.2) | 4 (6.3) |
 Clear cell | 5 (5.2) | 3 (9.1) | 2 (3.2) |
 Mixed/Undifferentiated | 8 (8.3) | 2 (6.1) | 6 (9.5) |
 No data | 1 (1.1) | 0 (0) | 1 (1.6) |
FIGO stage | |||
 IA | 5 (5.2) | 3 (9.1) | 2 (3.2) |
 IB | 4 (4.1) | 2 (6.1) | 2 (3.2) |
 IC | 15 (15.6) | 8 (24.3) | 7 (11.1) |
 IIA | 2 (2.1) | 0 (0) | 2 (3.2) |
 IIB | 1 (1.1) | 1 (3.0) | 0 (0) |
 IIC | 8 (8.3) | 3 (9.1) | 5 (7.9) |
 IIIA | 3 (3.1) | 1 (3.0) | 2 (3.2) |
 IIIB | 9 (9.4) | 1 (3.0) | 8 (12.7) |
 IIIC | 36 (37.5) | 11 (33.3) | 25 (39.6) |
 IV | 12 (12.5) | 2 (6.1) | 10 (15.9) |
 not staged | 1 (1.1) | 1 (3.0) | 0 (0) |
Grade | |||
 G1 | 5 (5.2) | 3 (9.1) | 2 (3.2) |
 G2 | 10 (10.4) | 6 (18.2) | 4 (6.3) |
 G3 | 78 (81.3) | 23 (69.7) | 55 (87.3) |
 unknown | 3 (3.1) | 1 (3.0) | 2 (3.2) |